Kate Farms, producer of plant-based, organic, clinically proven formulas for tube feeding to help nourish those with chronic illnesses, announced today that Main Street Advisors has joined Goldman Sachs and Kaiser Permanente Ventures in Kate Farms‘ Series B funding round, bringing the final raise to $60 million.
Kate Farms Closes $75M Series C Round to Expand Plant-Based Nutrition in Hospitals
Kate Farms, a leader in plant-based nutritional formulas, announces it has closed $75M in Series C funding, in a round led by life science investor Novo Holdings. The funding brings the company’s total raise to over $135M, and will be used to fuel additional innovation in the brand’s portfolio, develop new products and enter new market channels. “I’m pleased that… investors appreciate the significant potential of plant-based nutrition and Kate Farms’ leadership in this rapidly growing market” Accessible in over 95% of US hospitals, including top children’s hospitals, Kate Farms produces plant-based, organic and clinically demonstrated formulas for those with chronic illnesses and acute conditions. Its entire product portfolio, used for tube and oral feeding, is USDA organic and non-GMO certified, while being free from common …
